Oncology Elevated Counts and Thrombotic Risk in Patients With Polycythemia Vera patient care perspectives By Rami S. Komrokji, MD
Oncology Resistance or Intolerance to Hydroxyurea in Patients With Polycythemia Vera patient care perspectives By Ruben A. Mesa, MD, FACP
Oncology Treatment Recommendations for Durable Count Control in Polycythemia Vera clinical topic updates By Ruben A. Mesa, MD, FACP
Oncology Traditional and Nontraditional Risk Factors in Patients With Myeloproliferative Neoplasms clinical topic updates By Rami S. Komrokji, MD
Oncology Most Effective Outcome Measures for Assessing Treatment Response in Relapsed/Refractory Chronic Lymphocytic Leukemia expert roundtables By Bruce D. Cheson, MD, FACP, FAAAS, FASCO; Jennifer R. Brown, MD, PhD